Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-α
- 1 May 1997
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 34 (3) , 101-111
- https://doi.org/10.1016/s0166-3542(97)01028-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Myocardial enterovirus infection with left ventricular dysfunction: A benign disease compared with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1995
- Adverse Effects and Drug Interactions of Clinical Importance with Antiviral DrugsDrug Safety, 1994
- Direct Myocardial Injury by Enterovirus: A Central Role in the Evolution of Murine MyocarditisClinical Immunology and Immunopathology, 1993
- Comparative Pharmacokinetics of Antiviral Nucleoside AnaloguesClinical Pharmacokinetics, 1993
- Synergistic Interaction of Interferon- and Interferon- in Coxsackievirus B3-Infected Carrier Cultures of Human Myocardial FibroblastsThe Journal of Infectious Diseases, 1992
- Evolving concepts of cause, consequence, and control in myocarditisCurrent Opinion in Cardiology, 1991
- Clinical Pharmacokinetics of InterferonsClinical Pharmacokinetics, 1990
- A Prospective, Randomized, Controlled Trial of Prednisone for Dilated CardiomyopathyNew England Journal of Medicine, 1989
- Recently diagnosed idiopathic dilated cardiomyopathy: Incidence of myocarditis and efficacy of prednisone therapyAmerican Heart Journal, 1989
- Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in miceAmerican Heart Journal, 1988